Aaron Cohen-Gadol

Longeviti Launches ClearFit Covers, Allowing Post-Operative Ultrasound Imaging for Brain Surgery Patients

Retrieved on: 
Tuesday, March 9, 2021

Longeviti Neuro Solutions , a medtech company developing innovative solutions for complex brain surgery, today announced the launch of the Longeviti ClearFit Cover.

Key Points: 
  • Longeviti Neuro Solutions , a medtech company developing innovative solutions for complex brain surgery, today announced the launch of the Longeviti ClearFit Cover.
  • The first-of-its-kind sonolucent ClearFit Cover is used to replace excised cranial bone following a neurosurgical procedure, enabling neurosurgeons to use ultrasound imaging to view neuroanatomy after brain surgery, and allowing long-term monitoring of their patients condition.
  • Now, surgeons can use a Longeviti ClearFit Cover to repair the cranial void and serve as a neuroimaging diagnostic tool.
  • Longevitis focus is to develop innovative solutions for complex brain surgery that return patients to anatomical normalcy.

Barrow Receives Largest Grant in History To Seek Cure for Deadly Brain Cancer

Retrieved on: 
Monday, September 10, 2018

PHOENIX, Sept. 10, 2018 /PRNewswire/ -- Barrow Neurological Institute has initiated a $50 million effort, supported by the single largest research grant in the history of brain tumor research, to seek a cure for the deadliest form of brain cancer.

Key Points: 
  • PHOENIX, Sept. 10, 2018 /PRNewswire/ -- Barrow Neurological Institute has initiated a $50 million effort, supported by the single largest research grant in the history of brain tumor research, to seek a cure for the deadliest form of brain cancer.
  • "This grant will fast track discovery and offer support and hope to those battling glioblastoma and other malignant brain tumors," says Nader Sanai, MD, director of neurosurgical oncology.
  • Catherine Ivy, president of The Ben and Catherine Ivy Foundation, said the Center's ultimate goal is to cure brain cancer.
  • "After years of assessment, we have decided to invest in the Ivy Brain Tumor Center at Barrow.